Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy L Tarone, G Barutello, S Iussich, D Giacobino, E Quaglino, P Buracco, ... Cancer Immunology, Immunotherapy 68, 1839-1853, 2019 | 49 | 2019 |
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota A Di Lorenzo, E Bolli, L Tarone, F Cavallo, L Conti International journal of molecular sciences 21 (24), 9418, 2020 | 46 | 2020 |
Strengths and weaknesses of pre-clinical models for human melanoma treatment: dawn of dogs’ revolution for immunotherapy G Barutello, V Rolih, M Arigoni, L Tarone, L Conti, E Quaglino, P Buracco, ... International journal of molecular sciences 19 (3), 799, 2018 | 45 | 2018 |
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source R Ruiu, L Tarone, V Rolih, G Barutello, E Bolli, F Riccardo, F Cavallo, ... Progress in molecular biology and translational science 164, 119-188, 2019 | 39 | 2019 |
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma F Riccardo, L Tarone, S Iussich, D Giacobino, M Arigoni, F Sammartano, ... Therapeutic Advances in Medical Oncology 11, 1758835919855491, 2019 | 25 | 2019 |
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA … D Giacobino, M Camerino, F Riccardo, F Cavallo, L Tarone, M Martano, ... Veterinary and Comparative Oncology 19 (4), 651-660, 2021 | 16 | 2021 |
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020) M Camerino, D Giacobino, L Manassero, S Iussich, F Riccardo, F Cavallo, ... Veterinary and Comparative Oncology 20 (1), 189-197, 2022 | 13 | 2022 |
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial F Riccardo, L Tarone, M Camerino, D Giacobino, S Iussich, G Barutello, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 8 | 2022 |
Canine melanoma immunology and immunotherapy: relevance of translational research L Tarone, D Giacobino, M Camerino, S Ferrone, P Buracco, F Cavallo, ... Frontiers in Veterinary Science 9, 803093, 2022 | 5 | 2022 |
Improving osteosarcoma treatment: comparative oncology in action L Tarone, K Mareschi, E Tirtei, D Giacobino, M Camerino, P Buracco, ... Life 12 (12), 2099, 2022 | 4 | 2022 |
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma L Tarone, D Giacobino, M Camerino, L Maniscalco, S Iussich, L Parisi, ... Molecular Therapy 31 (8), 2342-2359, 2023 | 3 | 2023 |
Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas F Riccardo, G Barutello, A Petito, L Tarone, L Conti, M Arigoni, C Musiu, ... Vaccines 8 (2), 166, 2020 | 3 | 2020 |
Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation L Tarone, P Buracco, F Cavallo, F Riccardo Electroporation in Veterinary Oncology Practice: Electrochemotherapy and …, 2021 | 2 | 2021 |
Anti-CSPG4 DNA vaccination as a promising strategy for the treatment of CSPG4+ tumours: A comparative oncology trial F Riccardo, L Tarone, G Barutello, M Arigoni, D Giacobino, S Iussich, ... Annals of Oncology 30, v497, 2019 | 1 | 2019 |
OmniReprodubileCellAnalysis: a comprehensive toolbox for the analysis of cellular biology data D Tortarolo, S Pernice, F Clapero, D Valdembri, G Serini, F Riccardo, ... 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2023 | | 2023 |
OmniReprodubileCellAnalysis: a comprehensive toolbox for the analysis of cellular biology data T Dora, P Simone, F Clapero, D Valdembri, G Serini, F Riccardo, L Tarone, ... | | 2023 |
A chimeric Human/Dog CSPG4 DNA vaccine reveals potential therapeutic effects for the treatment of melanoma F Riccardo, L Tarone, D Giacobino, M Camerino, G Barutello, M Arigoni, ... CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY, 39, 2023 | | 2023 |